Publications

Search or filter publications

Search publications Search

Filter by type:

Filter by publication type

• Book
• Book chapter
• Conference paper
• Journal article
• Patent
• Report
• Software

Filter by year:

Filter from 20252024202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997 to Filter to 20252024202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997

---

Search results

• Journal article
  Thongyoo P, Bonomelli C, Leatherbarrow RJ, Tate EWet al., 2009,

  Potent Inhibitors of β-Tryptase and Human Leukocyte Elastase Based on the MCoTI-II Scaffold

  , JOURNAL OF MEDICINAL CHEMISTRY, Vol: 52, Pages: 6197-6200, ISSN: 0022-2623
  • Author Web Link
  • Cite
  • Citations: 104
• Journal article
  Heal WP, Wickramasinghe SR, Tate EW, 2008,

  Activity based chemical proteomics: profiling proteases as drug targets.

  , Curr Drug Discov Technol, Vol: 5, Pages: 200-212, ISSN: 1570-1638

  The pivotal role of proteases in many diseases has generated considerable interest in their basic biology, and in the potential to target them for chemotherapy. Although fundamental to the initiation and progression of diseases such as cancer, diabetes, arthritis and malaria, in many cases their precise role remains unknown. Activity-based chemical proteomics-an emerging field involving a combination of organic synthesis, biochemistry, cell biology, biophysics and bioinformatics-allows the detection, visualisation and activity quantification of whole families or selected sub-sets of proteases based upon their substrate specificity. This approach can be applied for drug target/lead identification and validation, the fundamentals of drug discovery. The activity-based probes discussed in this review contain three key features; a 'warhead' (binds irreversibly but selectively to the active site), a 'tag' (allowing enzyme 'handling', with a combination of fluorescent, affinity and/or radio labels), and a linker region between warhead and tag. From the design and synthesis of the linker arise some of the latest developments discussed here; not only can the physical properties (e.g., solubility, localisation) of the probe be tuned, but the inclusion of a cleavable moiety allows selective removal of tagged enzyme from affinity beads etc. The design and synthesis of recently reported probes is discussed, including modular assembly of highly versatile probes via solid phase synthesis. Recent applications of activity-based protein profiling to specific proteases (serine, threonine, cysteine and metalloproteases) are reviewed as are demonstrations of their use in the study of disease function in cancer and malaria.

  • Abstract
  • Author Web Link
  • Cite
• Journal article
  Busch GK, Tate EW, Gaffney PR, Rosivatz E, Woscholski R, Leatherbarrow RJet al., 2008,

  Specific N-terminal protein labelling: use of FMDV 3C pro protease and native chemical ligation

  , Chem.Commun.(Camb.), Pages: 3369-3371

  We report an effective strategy for generating N-terminal cysteinyl proteins by proteolytic cleavage using the enzyme 3C pro, suitable for a wide range of applications via native chemical ligation

  • Abstract
  • Author Web Link
  • Cite
• Journal article
  Heal WP, Wickramasinghe SR, Leatherbarrow RJ, Tate EWet al., 2008,

  N-Myristoyl transferase-mediated protein labelling in vivo

  , Organic and Biomolecular Chemistry
  • Publisher Web Link
  • Cite
• Journal article
  Tate EW, 2008,

  Recent advances in chemical proteomics: exploring the post-translational proteome

  , Journal of Chemical Biology, Vol: 1, Pages: 1-1

  Identification and quantification of multiple proteins from complex mixtures is a central theme in post-genomic biology. Despite recent progress in high-throughput proteomics, proteomic analysis of post-translationally modified (PTM) proteins remains particularly challenging. This mini-review introduces the emerging field of chemical proteomics and reviews recent advances in chemical proteomic technology that are offering striking new insights into the functional biology of post-translational modification.

  • Abstract
  • Publisher Web Link
  • Cite
• Journal article
  Bowyer PW, Tate EW, Leatherbarrow RJ, Holder AA, Smith DF, Brown KAet al., 2008,

  <i>N</i>-myristoyltransferase:: a prospective drug target for protozoan parasites

  , CHEMMEDCHEM, Vol: 3, Pages: 402-408, ISSN: 1860-7179
  • Author Web Link
  • Cite
  • Citations: 54
• Journal article
  Heal WP, Wickramasinghe SR, Bowyer PW, Holder AA, Smith DF, Leatherbarrow RJ, Tate EWet al., 2008,

  Site-specific N-terminal labelling of proteins in vitro and in vivo using N-myristoyl transferase and bioorthogonal ligation chemistry

  , Chem. Commun.
  • Publisher Web Link
  • Cite
• Journal article
  Thongyoo P, Roque-Rosell N, Leatherbarrow RJ, Tate EWet al., 2008,

  Chemical and biomimetic total syntheses of natural and engineered MCoTI cyclotides

  , ORGANIC & BIOMOLECULAR CHEMISTRY, Vol: 6, Pages: 1462-1470, ISSN: 1477-0520
  • Author Web Link
  • Cite
  • Citations: 124
• Journal article
  Bowyer PW, Gunaratne RS, Grainger M, Withers-Martinez C, Wickramsinghe SR, Tate EW, Leatherbarrow RJ, Brown KA, Holder AA, Smith DFet al., 2007,

  Molecules incorporating a benzothiazole core scaffold inhibit the N-myristoyltransferase of <i>Plasmodium falciparum</i>

  , BIOCHEMICAL JOURNAL, Vol: 408, Pages: 173-180, ISSN: 0264-6021
  • Author Web Link
  • Cite
  • Citations: 55
• Journal article
  Thongyoo P, Jaulent AM, Tate EW, Leatherbarrow RJet al., 2007,

  Immobilized protease-assisted synthesis of engineered cysteine-knot microproteins

  , CHEMBIOCHEM, Vol: 8, Pages: 1107-1109, ISSN: 1439-4227
  • Author Web Link
  • Cite
  • Citations: 42

This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.